Document Detail


Balancing antiplatelet and anticoagulant therapies in patients with cardiovascular disease.
MedLine Citation:
PMID:  25135291     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Anticoagulation is needed for stroke prevention in patients with atrial fibrillation. Antiplatelet therapy is essential for the prevention of stent thrombosis and the reduction of cardiovascular events in patients who undergo coronary stenting and suffer acute coronary syndromes. When these conditions overlap, the individual antithrombotic strategies are commonly combined, and the efficacy benefit of triple oral antithrombotic therapy is assumed to outweigh the bleeding risk based on the available data. Recent studies have investigated this topic further, including the first randomized controlled trial to address this issue. This new evidence challenges previous assumptions and may have implications for future practice and investigation.
Authors:
Edward T Carreras; Jessica L Mega
Publication Detail:
Type:  Journal Article     Date:  2013-04-25
Journal Detail:
Title:  Cardiology and therapy     Volume:  2     ISSN:  2193-8261     ISO Abbreviation:  Cardiol Ther     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2014-08-19     Completed Date:  2014-08-19     Revised Date:  2014-08-22    
Medline Journal Info:
Nlm Unique ID:  101634495     Medline TA:  Cardiol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  85-96     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Optimal choice of coronary revascularization and stent type in diabetic patients with coronary arter...
Next Document:  Fenestrated atrial septal defect percutaneously occluded by a single device: procedural and financia...